ARH Hazard
200 Medical Center Drive
Hazard, Kentucky 41701

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Chronic Phase Chronic Myeloid Leukemia Clinical Trial
Determining Change in Cardiovascular and Metabolic Risks in Patients With Chronic Phase Chronic Myeloid Leukemia Receiving BCR-ABL Tyrosine Kinase Inhibitor First-Line Therapy in the United States
Status: Enrolling, Phase
Updated: 12/31/1969
ARH Hazard
mi
from
Hazard, KY
Click here to add this to my saved trials